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1. Introduction 
Because incubation of [U-14~]phenylalanine or 
tyrosine with muscle preparations does not produce 
r4C02, it is assumed that these aromatic amino acids 
are poorly metabolised [l-3]. Release of aromatic 
amino acids from muscle preparations in the presence 
of cycloheximide has therefore been used as an index 
of muscle protein degradation. However, there is 
some evidence that aromatic amino acids may be at 
least transaminated by muscle [4,5]. This might inter- 
fere with methods of detection which are dependent 
upon the presence of an amino group, e.g., amino 
acid analysis or the amino acyl tRNA synthetase 
method [6]. Here, the transamination of aromatic 
amino acids by homogenates and whole tissue prepa- 
rations is reported. 
2. Experimental 
Radiochemicals were from The Radiochemical 
Centre, Amersham HP7 9LL. Biochemicals and other 
chemicals were either from Sigma (London) Chemical 
Co., Poole BHI7 7NH, or BDH Chemicals, Poole 
BH 12 4NN. 
2.2. Homogenization 
Rats were killed by a blow on the head and cervi- 
cal dislocation. Hearts were removed, rinsed in 0.9% 
(w/v) NaCl, frozen in liquid N2 then homogenized at 
0°C in 50 mM potassium phosphate/O.1 mM pyri- 
doxal phosphate (pH 6.8) (1 g tissue f 4 vol. buffer) 
using a Polytron homogenizer (Kinematica Gmbh., 
CH-6005 Luzern) at mark 10 until the tissue was 
completely dispersed. Homogenates were centrifuged 
at 1.50 000 X g for 5 mm and supernatants (some- 
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times dialyzed overnight at 4°C against homogeniza- 
tion buffer) were used in experiments. 
2.3. Radiochemical assay of aminotransferase activity 
In pyridoxal phosphate-dependent transamination, 
a proton from the 2-position of the amino acid is lost 
to water [7,8/. If the 2-hydrogen is replaced by a 
tritium atom, 3H,0 formed during transamination 
can be easily separated from the amino acid by ion- 
exchange chromatography. There are problems with 
this approach (exchange reactions, racemases or 
L-amino acid oxidase also remove the 2-proton, only 
[2,3-3H] amino acids commercially available). These 
can be circumvented if it can be shown that: (i> the 
appearance of 3H,0 is dependent on the presence of 
an amino-group accepting 2-0~0 acid; (ii) that any 
2-0~0 ]3-3H] acid product can be quantitatively 
separated from 3H,0 or [2,3-3H]amino acid sub- 
strate. 
Alanine aminotransferase (EC 2.6.1.2) was assayed 
at 30°C in 0.4 ml containing 50 mM potassium phos- 
phate (pH 6.8)/0.1 mM pyridoxal phosphate~lo mM 
2-oxoghrtarate (pH 7 with KOH)/37.5 mM L-[2,3-3H]- 
alanine (spec. radioact. 1 $J/pmol) and 4 pg enzyme 
(Sigma lot 69C-984 1 diluted in 90 mM potassium 
phosphate (pH 6.8)10.2 mM pyridoxal phosphates 
1 mg bovine serum albuminfml). A 50 ~1 sample was 
removed at various times and 25 /..d 1 M HCl added. 
A sample (50-70 ~1) of terminated reaction mixture 
was transferred to a column (0.5 X 3 cm) of Dowex 
5OW X 4 (H+ form) precycled as in [9]. An initial 
water (0.5 ml) wash was discarded, products were 
eluted with two 0.5 ml water washes into scintillation 
vials and counted in toluene-methoxyethanol based 
scintillant [lo]. 
Phenylalanine aminotransferase activity was esti- 
mated similarly except that L-phenyl [2,3-3H]alanine 
(section 3 for concentrations) replaced alanine and 
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rat heart supernatant replaced alanine aminotrans- 
ferase. 
For both assays: 
(i) 3Hz0 and 2-0~0 acid product were stoicheio- 
metrically recovered; 
(ii) 98-99% L-[2,3-3H]amino acid was retained by 
the column; 
(iii) Appearance of radioactivity above the blank 
values was dependent upon the presence of 
2-oxoghttarate; 
(iv) The time course was linear for at least 10 min; 
(v) The rate of product appearance was linear with 
enzyme added. 
2.4. Tissue preparations 
For the isolated diaphragm, male fed rats 
(So-100 g) were killed by a blow on the head and 
decapitation. Diaphragms were removed into Krebs- 
Henseleit bicarbonate solution [ 1 l] at 25°C equili- 
brated with 95% 0,/S% CO* in the absence or pres- 
ence of glucose (section 3). Diaphragms were cut into 
halves or quarters, blotted lightly and weighed into 
25 ml Erlenmeyer flasks or scintillation vials contain- 
ing 2-3 ml Krebs-Henseleit bicarbonate solution with 
additions described in section 3. Diaphragms were 
preincubated in a shaking water bath (60 cycles/min) 
at 37°C for 30 min and were then placed in fresh media 
for the 2 h test incubation. During this time, the 
media were deproteinized by the addition of per- 
chloric acid (0.05 vol.) and centrifugation, or metabo- 
lism stopped by addition of 0.5 vol. 1 M HCl. 
Heart perfusions were carried out essentially as 
in [ 121. Male fed rats (300-400 g) were killed by the 
intraperitoneal injection of 1 ml Sagatal (May and 
Baker, Dagenham, Essex) and hearts removed into 
ice-cold 0.9% (w/v) NaCl. Hearts were perfused using 
recirculation of 15 ml medium (+lO mM glucose) 
after an initial wash-through of 15 ml medium. 
L-Phenyl [2,3-3H] alanine (0.1 mM, 1 pCi/ml) was 
added to the medium after the wash-through. Sam- 
ples (50 ~1) were analyzed for [3H] products as in 
section 2.3. Samples (10 ~1) were removed from the 
terminated extracts for the determination of total 
radioactivity. 
2.5. Other methods 
Alanine aminotransferase was assayed spectro- 
photometrically as in [13] at 37.5 mM L-alanine and 
pH 6.8. The reaction was initiated by the addition 
of 0.25-0.75 pg enzyme diluted as above. (1 unit = 
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1 pmol substrate used/min at 30°C). Alanine in 
HClO&reated media (adjusted to pH 10 with KOH 
and stood at 0°C for 1 h) was assayed as in [ 141 at 
pH 8.5 using alanine dehydrogenase dialyzed against 
5 mM EDTA (pH 7.5). Blank incubations used HClO,, 
treated Krebs-Henseleit buffer containing appropriate 
concentrations of aromatic amino acids. 
3. Results 
3 .I . Validity of the radiochemical method of mea- 
surement of aminotransferase activity 
Assays for alanine aminotransferase were carried 
out spectrophotometrically and radiochemically by 
construction of a plot of enzyme activity versus 
enzyme added (,ug). From the slope (not shown), the 
specific activity was calculated. The radiochemical 
assays gave an activity of 26.9 units/mg enzyme at 
30°C and the spectrophotometric method gave 26.3 
units/mg enzyme, proving the validity of the radio- 
chemical method and showing (with the controls in 
section 2.3) that it measures flux through the reac- 
tion rather than an isotope exchange of the part 
reaction. The rate of product appearance was linear 
with enzyme concentration to 10 pg protein /ml. 
3.2. Phenylalanine transamination by rat heart 
supernatan ts 
Incubation of rat heart supernatants with L-phenyl 
[2,3-3H]alanine produced radioactivity which was 
not retained by the cationic ion-exchange column. 
Control experiments (section 2.3) suggest hat this is 
consistent with phenylalanine being transaminated 
to form glutamate, phenyl [3-3H]pyruvate and 3Hz0. 
The nature of the products was not well characterized 
but under the conditions of this initial rate study, it 
is presumed that tritium will be present in phenyl- 
pyruvate rather than any more extensively metabo- 
lised product (if this can occur at all). The V,, 
and app. Km of phenylalanine aminotransferase for 
phenylalanine (fig.1) were 12.23 * 0.13 pmol 
30 min-‘. g fresh wt heart-’ and 20.3 + 0.6 mM, 
respectively (10 mM 2-oxoglutarate, 3O”C, results as 
means ? SEM for 12 = 3). Aminooxyacetate (an inhi- 
bitor of pyridoxal phosphate-dependent enzymes, 
see [ 151) inhibited phenylalanine transamination 
(fig.2). Neither commercially-available pig heart 
alanine aminotransferase nor aspartate aminotrans- 
ferase (EC 2.6.1 .l) catalysed phenylalanine transami- 
nation (not shown). 
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Fig.1. Reciprocal plot for phenylalanine aminotransferase of
rat heart supernatant fraction. Incubations were at 30°C for 
30 min. The incubation volume was 100 cl1 and contained 
20 mM potassium phosphate (pH 6.8)fO.l mM pyridoxal 
phosphate/l0 mM 2-oxoglutarate (neutralized)/O.S &i 
L-phenyl [ 2,3-aH]alanine plus various amounts of L-phenyl- 
alanine. The reaction was initiated by addition of rat heart 
supernatant fraction (40 ~1) prepared as in section 2.2. It 
was terminated by the addition of 1 M HCl (SO ~1) and prod- 
ucts separated as in section 2.3. Results were plotted by the 
Lineweaver-Burk method [ 201. 
3.3. Metabolism of L-phenyl f2,3-3Hfalanine by the 
perfused rat heart and the isolated rat diaphragm 
Perfusion of rat hearts with media containing 
0.1 mM L-phenyl ~~,3-3H]alanine produced radio- 
activity which was not retained by cationic ion- 
exchange columns (fig.3a). This was presumably 
3Hz0 and pheny 1 3 H [ -3 ] py ruvate. The phenylalanine 
concentration in the perfusate was approximately the 
same as in rat plasma [ 161. Metabolism of phenyl- 
alanine was inhibited by 1 mM aminooxyacetate 
(fig.3a). Since the products of transamination of 
pheny~alanine in the perfusate were not well charac- 
terized and since phenylalanine is released from the 
heart during perfusion, an accurate estimate of the 
rate of phenylaianine transamination is not possible. 
Thus, resufts are expressed in terms of [ 3H] product 
produced in ng atom/g dry wt heart based upon the 
original specific radioactivity. However, by making 
certain assumptions, the rate of phenyl~anine trans- 
amination can be calculated and can be compared 
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Fig.2. Inhibition of phenylalanine transaminase by amino- 
oxyacetate. Incubations were as described in fig.1 except that 
L-phenylalanine was 1 mM and the incubations also contained 
various concentrations of aminooxyacetate (neutralized to 
pH 7 with KOH). Phenylalanine transaminase activity is 
expressed as the percentage of control activity in the absence 
of aminooxyacetate. 
to the rate of transamination in heart extracts. The 
following assumptions were made: 
(i) Phenyl [3-3H] pyruvate was not metaboiised 
further and is released into the perfusate; 
(ii) The enzyme activity doubled for an 8°C rise in 
temperature; 
(iii) The contribution of endogenous pheny~alan~ne 
was small. 
(The calculated contribution of endogenous phenyl- 
alanine to the perfusate phenylalanine was only 
~10%) From the data in fig.3a, the rate of transami- 
nation of phenylalanine by the perfused heart was 
0.025 pm01 . 30 min-’ . g fresh wt-’ at 0.1 mM phen- 
ylalanine. This compares with a computed rate of 
0,125 pmol .30 min-’ . g fresh wt-’ using data in 
section 3.2. 
The isolated rat diaphragm also metabolised phen- 
ylalanine (fig.3b). The appearance of [3H] product in 
the incubation medium was linear with time for 22 h. 
The rate of phenylalanine transamination was linear 
over O.l- 1 mM phenylalanine. This is presumably a 
consequence of the relatively high app. K, of the 
aminotransferase for phenyialanine. 
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Fig.3. Metabolism of phenylalanine by the perfused rat heart 
and isolated rat diaphra~rll. Tissues were incubated as in sec- 
tion 2.4. In (a) the transamination of L-phenyl [2,3-3H]- 
alanine (0.1 mM) by the perfused heart is shown (a). The 
inhibition of L-phenyl [ 2,3-3H]alanine (0.1 mM) transamina- 
tion by 1 mM aminooxyacetate is also shown (A). In (b) the 
concentration dependence of L-phenyl [2,3-3H]alanine trans- 
amination by the isolated hemidiaphragm is shown. Dia- 
phragm incubations were in 2 ml Krebs-Henseleit medium 
[ 1 l] containing half the normal calcium concentration and 
supplemented with 10 mM glucose and 0.5 mM cycloheximide. 
After 30 mm preincubation, diaphragms were transferred to 
fresh media containg 10 PCi L-phenyl [2,3-3H]alanine and 
carrier L-phenylalanine as indicated, in addition to the addi- 
tions in the preincubation. Samples (SO ~1) were withdrawn 
at 30 min intervals and 25 ~1 1 M NC1 added. Products were 
separated from pheny~alanine asin section 2.3. 
3.4. Stimulation of alar&e release from the isolated 
diaphragm by aromatic amino acids 
Appearance of [3H]product from phenylalanine 
metaboIism does not demonstrate that there is any 
net flux through the phenylalanine transamination 
reaction. It could result from an isotope exchange 
reaction. Both phenylalanine and tyrosine stimulated 
alanine formation in the isolated diaphragm. Rates of 
alanine forrnatiotl + SEM (nmoi .2 h-r . g fresh wt -‘) 
were: 
Control 2.20 + 0.14 (n = 6), t3.3 mM phenylalanine 
2.64 f 0.13 (n = 6); 
Control 1.98 +_ 0.22 (n = S), t3.3 mM tyrosine 
2.63 + 0.16 (n = 11); 
t 10 mM glucose 3.05 4 0.08 (tz = 5), t 10 mM glucose 
and 3.33 mM phenyialanine 3.74 ir 0.15 (n = 5). 
Rates of alanine formation for + amino acids vs - 
amino acid incubations were significant at at least 
p G 0.05 (Student’s t-test). This shows there is a net 
flux through aromatic amino acid transanlination, Aro- 
matic amino acids cannot form citric acid cycle 
intermediates in the diaphragm since ]U-14C]aromatic 
amino acids do not produce 14C02 [2]. Formation 
of alanine presumably proceeds via transamination 
of glycolytically produced pyruvate, either directly 
or via iIlcreasing the amino group pool available for 
transall~ination, rather than by providing carbon for 
de novo synthesis of pyruvate via the phosphoenol 
pyruvate carboxykinase reaction [ 171. Because con- 
centrations of aromatic amino acids used in these 
experiments were -30-times plasma concentrations, 
there must be doubt about the physiological signifi- 
cance of alanine formation under these conditions. 
4. Discussion 
Both the heart and diaphragm can transarninate 
aromatic amino acids. They possess a phenylalanine 
aminotransferase distinct from alanine or aspartate 
aminotransferase. This casts doubt on the use of 
aromatic amino acid release in the presence of cyclo- 
heximide as a measure of muscle proteolysis. Sub- 
stances which increase transami~latable 2-0x0 acid 
concentrations might therefore decrease aromatic 
amino acid release. The enzyme(s) responsible for 
aromatic amino acid transamination is not known. 
In rat liver, there is a tyrosine-2-oxoglutarate amino- 
transferase (EC 2.6.1.5) which also poorly transamin- 
ates phenylalanine [ 1 S] and a phenylalal~ine-pyru- 
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vate aminotransferase [191. This report also shows 
that high concentrations of aromatic amino acid 
stimulate alanine release from the diaphragm and 
provide an enzymological basis for this. 
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